View More View Less
  • 1 Semmelweis Egyetem, Általános Orvostudományi Kar Neurológiai Klinika Budapest Balassa u. 6. 1083
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $1,070.00

A cardiovascularis betegségeknek és a krónikus veseelégtelenségnek több közös kockázati tényezőjük van, mint például a hipertónia és a diabétesz. Krónikus veseelégtelenségben a stroke kockázata többszörös az átlagpopulációhoz képest. A magasabb rizikó oka feltehetően a hagyományos és a veseelégtelenségre speciális rizikófaktorok halmozódása. Az akut cerebrovascularis betegségek között krónikus veseelégtelenségben gyakoribbak az állományvérzések, mint az átlagpopulációban. A stroke kimenetele rosszabb krónikus veseelégtelenségben. Ebben a betegcsoportban a stroke kezelése (thrombolysis, thrombocytaaggregáció gátlása és antikoagulálás, statinok alkalmazása stb.) jelenleg klinikai vizsgálatok tárgya. A thrombolysis akut stroke-ban való alkalmazhatóságáról krónikus veseelégtelenségben nincsenek megbízható adatok. Az aszpirin adható. Óvatosság, egyéni megfontolás és alacsonyabb adagok jönnek szóba az egyéb kezelési eljárások alkalmazásakor. A vérnyomáscsökkentők és lipidcsökkentők alkalmazásakor figyelembe kell venni a vese állapotán kívül az egyéb kísérőbetegségeket is.

  • Brouns, R., De Deyn, P. P.: Neurological complications in renal failure: a review. Clin. Neurol. Neurosurg., 2004, 107 , 1–16.

    Deyn P. P. , 'Neurological complications in renal failure: a review ' (2004 ) 107 Clin. Neurol. Neurosurg. : 1 -16.

    • Search Google Scholar
  • Kanai, H., Hirakata, H., Nakane, H. és mtsai: Depressed cerebral oxygen metabolism in patients with chronic renal failure: a positron emission tomography study. Am. J. Kidney Dis., 2001, 38 (4 Suppl. 1) , S129–S133.

    Nakane H. , 'Depressed cerebral oxygen metabolism in patients with chronic renal failure: a positron emission tomography study ' (2001 ) 38 Am. J. Kidney Dis. : S129 -S133.

    • Search Google Scholar
  • Nakatani, T., Naganuma, T., Uchida, J. és mtsai: Silent cerebral infarction in hemodialysis patients. Am. J. Nephrol., 2003, 23 , 86–90.

    Uchida J. , 'Silent cerebral infarction in hemodialysis patients ' (2003 ) 23 Am. J. Nephrol. : 86 -90.

    • Search Google Scholar
  • Baigent, C., Landray, M.: Which cardiovascular risk factors matter in chronic kidney disease? Nephrol. Dial. Transplant., 2007, 22 , 9–11.

    Landray M. , 'Which cardiovascular risk factors matter in chronic kidney disease? ' (2007 ) 22 Nephrol. Dial. Transplant. : 9 -11.

    • Search Google Scholar
  • Best, P. J., Holmes, D. R. Jr.: Chronic kidney disease as a cardiovascular risk factor. Am. Heart J., 2003, 145 , 383–386.

    Holmes D. R. , 'Chronic kidney disease as a cardiovascular risk factor ' (2003 ) 145 Am. Heart J. : 383 -386.

    • Search Google Scholar
  • Coresh, J., Astor, B., Sarnak, M. J.: Evidence for increased cardiovascular disease risk in patients with chronic kidney disease. Curr. Opin. Nephrol. Hypertens., 2004, 13 , 73–81.

    Sarnak M. J. , 'Evidence for increased cardiovascular disease risk in patients with chronic kidney disease ' (2004 ) 13 Curr. Opin. Nephrol. Hypertens. : 73 -81.

    • Search Google Scholar
  • Culleton, B. F., Hemmelgarn, B. R.: Is chronic kidney disease a cardiovascular disease risk factor? Semin. Dial., 2003, 16 , 95–100.

    Hemmelgarn B. R. , 'Is chronic kidney disease a cardiovascular disease risk factor? ' (2003 ) 16 Semin. Dial. : 95 -100.

    • Search Google Scholar
  • Sarnak, M. J., Levey, A. S., Schoolwerth, A. C. és mtsai: American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention: Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension, 2003, 42 , 1050–1065.

    Schoolwerth A. C. , 'American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention: Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention ' (2003 ) 42 Hypertension : 1050 -1065.

    • Search Google Scholar
  • Krane, V., Krieter, D. H., Olschewski, M. és mtsai: Dialyzer membrane characteristics and outcome of patients with type 2 diabetes on maintenance hemodialysis. Am. J. Kidney Dis., 2007, 49 , 267–275.

    Olschewski M. , 'Dialyzer membrane characteristics and outcome of patients with type 2 diabetes on maintenance hemodialysis ' (2007 ) 49 Am. J. Kidney Dis. : 267 -275.

    • Search Google Scholar
  • K/DOQI. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification. Part 4. Definition and classification of stages of chronic kidney disease. Am. J. Kidney Dis., 2002, 39 (Suppl. 1), S46–S75

  • Ruilope, L. M., Salvetti, A., Jamerson, K. és mtsai: Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study. J. Am. Soc. Nephrol., 2001, 12 , 218–225.

    Jamerson K. , 'Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study ' (2001 ) 12 J. Am. Soc. Nephrol. : 218 -225.

    • Search Google Scholar
  • Foley, R. N., Parfrey, P. S., Sarnak, M. J.: Epidemiology of cardiovascular disease in chronic renal disease. J. Am. Soc. Nephrol., 1998, 9 (Suppl. 12) , S16–23.

    Sarnak M. J. , 'Epidemiology of cardiovascular disease in chronic renal disease ' (1998 ) 9 J. Am. Soc. Nephrol. : S16 -23.

    • Search Google Scholar
  • Go, A. S., Chertow, G. M., Fan, D. és mtsai: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N. Engl. J. Med., 2004, 351 , 1296–1305.

    Fan D. , 'Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization ' (2004 ) 351 N. Engl. J. Med. : 1296 -1305.

    • Search Google Scholar
  • Weiner, D. E., Tighiouart, H., Amin, M. G. és mtsai: Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J. Am. Soc. Nephrol., 2004, 15 , 1307–1315.

    Amin M. G. , 'Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies ' (2004 ) 15 J. Am. Soc. Nephrol. : 1307 -1315.

    • Search Google Scholar
  • Nakamura, K., Okamura, T., Hayakawa, T. és mtsai: The NIPPON DATA90 Research Group: Chronic kidney disease is a risk factor for cardiovascular death in a community-based population in Japan: NIPPON DATA90. Circ. J., 2006, 70 , 954–959.

    Hayakawa T. , 'The NIPPON DATA90 Research Group: Chronic kidney disease is a risk factor for cardiovascular death in a community-based population in Japan: NIPPON DATA90 ' (2006 ) 70 Circ. J. : 954 -959.

    • Search Google Scholar
  • Toyoda, K., Fujii, K., Fujimi, S. és mtsai: Stroke in patients on maintenance hemodialysis: a 22-year single-center study. Am. J. Kidney Dis., 2005, 45 , 1058–1066.

    Fujimi S. , 'Stroke in patients on maintenance hemodialysis: a 22-year single-center study ' (2005 ) 45 Am. J. Kidney Dis. : 1058 -1066.

    • Search Google Scholar
  • Kawamura, M., Fijimoto, S., Hisanaga, S. és mtsai: Incidence, outcome, and risk factors of cerebrovascular events in patients undergoing maintenance hemodialysis. Am. J. Kidney Dis., 1998, 31 , 991–996.

    Hisanaga S. , 'Incidence, outcome, and risk factors of cerebrovascular events in patients undergoing maintenance hemodialysis ' (1998 ) 31 Am. J. Kidney Dis. : 991 -996.

    • Search Google Scholar
  • Seliger, S. L., Gillen, D. L., Longstreth, W. T. Jr. és mtsai: Elevated risk of stroke among patients with end-stage renal disease. Kidney Int., 2003, 64 , 603–609.

    Longstreth W. T. , 'Elevated risk of stroke among patients with end-stage renal disease ' (2003 ) 64 Kidney Int. : 603 -609.

    • Search Google Scholar
  • Seliger, S. L., Gillen, D. L., Trschwell, D. és mtsai: Risk factors for incident stroke among patients with end-stage renal disease. J. Am. Soc. Nephrol., 2003, 4 , 2623–2631.

    Trschwell D. , 'Risk factors for incident stroke among patients with end-stage renal disease ' (2003 ) 4 J. Am. Soc. Nephrol. : 2623 -2631.

    • Search Google Scholar
  • Adams, H. P. Jr., Dawson, G., Coffman, T. J. és mtsa: Stroke in renal transplant recipients. Arch. Neurol., 1986, 43 , 113–115.

    Coffman T. J. , 'Stroke in renal transplant recipients ' (1986 ) 43 Arch. Neurol. : 113 -115.

  • Oliveras, A., Roquer, J., Puig, J. M. és mtsai: Stroke in renal transplant recipients: epidemiology, predictive risk factors and outcome. Clin. Transplant., 2003, 17 , 1–8.

    Puig J. M. , 'Stroke in renal transplant recipients: epidemiology, predictive risk factors and outcome ' (2003 ) 17 Clin. Transplant. : 1 -8.

    • Search Google Scholar
  • Meisinger, C., Doring, A., Lowel, H.: KORA Study Group: Chronic kidney disease and risk of incident myocardial infarction and all-cause and cardiovascular disease mortality in middle-aged men and women from the general population. Eur. Heart J., 2006, 27 , 1245–1250.

    Lowel H. , 'KORA Study Group: Chronic kidney disease and risk of incident myocardial infarction and all-cause and cardiovascular disease mortality in middle-aged men and women from the general population ' (2006 ) 27 Eur. Heart J. : 1245 -1250.

    • Search Google Scholar
  • Shlipak, M. G., Fried, L. F., Cushman, M. és mtsai: Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. JAMA, 2005, 293 , 1737–1745.

    Cushman M. , 'Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors ' (2005 ) 293 JAMA : 1737 -1745.

    • Search Google Scholar
  • McCullough, P. A., Jurkovitz, C. T., Pergola, P. E. és mtsai: for the KEEP Investigators: Independent components of chronic kidney disease as a cardiovascular risk state: results from the Kidney Early Evaluation Program (KEEP). Arch. Intern. Med., 2007, 167 , 1122–1129.

    Pergola P. E. , 'for the KEEP Investigators: Independent components of chronic kidney disease as a cardiovascular risk state: results from the Kidney Early Evaluation Program (KEEP) ' (2007 ) 167 Arch. Intern. Med. : 1122 -1129.

    • Search Google Scholar
  • Iseki, K., Wakugami, K., Maehara, A. és mtsai: Evidence for high incidence of end-stage renal disease in patients after stroke and acute myocardial infarction at age 60 or younger. Am. J. Kidney Dis., 2001, 38 , 1235–1239.

    Maehara A. , 'Evidence for high incidence of end-stage renal disease in patients after stroke and acute myocardial infarction at age 60 or younger ' (2001 ) 38 Am. J. Kidney Dis. : 1235 -1239.

    • Search Google Scholar
  • Muntner, P., Coresh, J., Klag, M. J. és mtsai: History of myocardial infarction and stroke among incident end-stage renal disease cases and population-based controls: an analysis of shared risk factors. Am. J. Kidney Dis., 2002, 40 , 323–330.

    Klag M. J. , 'History of myocardial infarction and stroke among incident end-stage renal disease cases and population-based controls: an analysis of shared risk factors ' (2002 ) 40 Am. J. Kidney Dis. : 323 -330.

    • Search Google Scholar
  • Zsuga J., Török J., Magyar M. és mtsai: Serum asymmetric dimethylarginine negatively correlates with intima-media thickness in early-onset atherosclerosis. Cerebrovasc. Dis., 2007, 23 , 388–394.

    Magyar M. , 'Serum asymmetric dimethylarginine negatively correlates with intima-media thickness in early-onset atherosclerosis ' (2007 ) 23 Cerebrovasc. Dis. : 388 -394.

    • Search Google Scholar
  • Busch, M., Fleck, C., Wolf, G. és mtsa: Asymmetrical (ADMA) and symmetrical dimethylarginine (SDMA) as potential risk factors for cardiovascular and renal outcome in chronic kidney disease – possible candidates for paradoxical epidemiology? Amino Acids, 2006, 30 , 225–232.

    Wolf G. , 'Asymmetrical (ADMA) and symmetrical dimethylarginine (SDMA) as potential risk factors for cardiovascular and renal outcome in chronic kidney disease – possible candidates for paradoxical epidemiology? ' (2006 ) 30 Amino Acids : 225 -232.

    • Search Google Scholar
  • Ueda, S., Yamagishi, S., Matsumoto, Y, és mtsai: Asymmetric dimethylarginine (ADMA) is a novel emerging risk factor for cardiovascular disease and the development of renal injury in chronic kidney disease. Clin. Exp. Nephrol., 2007, 11 , 115–121.

    Matsumoto Y , 'Asymmetric dimethylarginine (ADMA) is a novel emerging risk factor for cardiovascular disease and the development of renal injury in chronic kidney disease ' (2007 ) 11 Clin. Exp. Nephrol. : 115 -121.

    • Search Google Scholar
  • Iseki, K., Kinjo, K., Kimura, Y. és mtsai: Evidence for high risk of cerebral hemorrhage in chronic dialysis patients. Kidney Int., 1993, 44 , 1086–1090.

    Kimura Y. , 'Evidence for high risk of cerebral hemorrhage in chronic dialysis patients ' (1993 ) 44 Kidney Int. : 1086 -1090.

    • Search Google Scholar
  • Yokoyama, S., Hirano, H., Uomizu, K. és mtsai: High incidence of microbleeds in hemodialysis patients detected by T2*-weighted gradient-echo magnetic resonance imaging. Neurol. Med. Chir. (Tokyo), 2005, 45 , 556–560.

    Uomizu K. , 'High incidence of microbleeds in hemodialysis patients detected by T2*-weighted gradient-echo magnetic resonance imaging ' (2005 ) 45 Neurol. Med. Chir. (Tokyo) : 556 -560.

    • Search Google Scholar
  • Watanabe, A.: Cerebral microbleeds and intracerebral hemorrhages in patients on maintenance hemodialysis. J. Stroke Cerebrovasc. Dis., 2007, 16 , 30–33.

    Watanabe A. , 'Cerebral microbleeds and intracerebral hemorrhages in patients on maintenance hemodialysis ' (2007 ) 16 J. Stroke Cerebrovasc. Dis. : 30 -33.

    • Search Google Scholar
  • Miyahara, K., Murata, H., Abe, H.: Predictors of intracranial hematoma enlargement in patients undergoing hemodialysis. Neurol. Med. Chir. (Tokyo), 2007, 47 , 47–52.

    Abe H. , 'Predictors of intracranial hematoma enlargement in patients undergoing hemodialysis ' (2007 ) 47 Neurol. Med. Chir. (Tokyo) : 47 -52.

    • Search Google Scholar
  • Iseki, K., Fukiyama, K., The Okinawa Dialysis Study (OKIDS) Group: Clinical demographics and long-term prognosis after stroke in patients on chronic haemodialysis. Nephrol. Dial. Transplant., 2000, 15 , 1808–1813.

    Fukiyama K. , 'Clinical demographics and long-term prognosis after stroke in patients on chronic haemodialysis ' (2000 ) 15 Nephrol. Dial. Transplant. : 1808 -1813.

    • Search Google Scholar
  • Murakami, M., Hamasaki, T., Kimura, S. és mtsai: Clinical features and management of intracranial hemorrhage in patients undergoing maintenance dialysis therapy. Neurol. Med. Chir. (Tokyo), 2004, 44 , 225–233.

    Kimura S. , 'Clinical features and management of intracranial hemorrhage in patients undergoing maintenance dialysis therapy ' (2004 ) 44 Neurol. Med. Chir. (Tokyo) : 225 -233.

    • Search Google Scholar
  • Tessone, A., Gottlieb, S., Barbash, I. M. és mtsai: Underuse of Standard Care and Outcome of Patients with Acute Myocardial Infarction and Chronic Renal Insufficiency. Cardiology, 2006, 108 , 193–199.

    Barbash I. M. , 'Underuse of Standard Care and Outcome of Patients with Acute Myocardial Infarction and Chronic Renal Insufficiency ' (2006 ) 108 Cardiology : 193 -199.

    • Search Google Scholar
  • Országos Gyógyszerészeti Intézet. Gyógyszer alkalmazási előirat Actilyse por iv. injekcióhoz vagy infúzióhoz. URL: www.ogyi.hu . Hozzáférés: 2007. október 4

  • Levey, A. S., Beto, J. A., Coronado, B. E. és mtsai: Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am. J. Kidney Dis., 1998, 32 , 853–906.

    Coronado B. E. , 'Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease ' (1998 ) 32 Am. J. Kidney Dis. : 853 -906.

    • Search Google Scholar
  • Vazquez, E., Sanchez-Perales, C., Borrego, F. és mtsai: Influence of atrial fibrillation on the morbido-mortality of patients on hemodialysis. Am. Heart J., 2000, 140 , 886–890.

    Borrego F. , 'Influence of atrial fibrillation on the morbido-mortality of patients on hemodialysis ' (2000 ) 140 Am. Heart J. : 886 -890.

    • Search Google Scholar
  • Vazquez, E., Sanchez-Perales, C., Garcia-Cortes, M. J. és mtsai: Ought dialysis patients with atrial fibrillation be treated with oral anticoagulants? Int. J. Cardiol., 2003, 87 , 135–141.

    Garcia-Cortes M. J. , 'Ought dialysis patients with atrial fibrillation be treated with oral anticoagulants? ' (2003 ) 87 Int. J. Cardiol. : 135 -141.

    • Search Google Scholar
  • Abbott, K. C.: Ought dialysis patients with atrial fibrillation be treated with oral anticoagulants? Int. J. Cardiol., 2005, 101 , 489.

    Abbott K. C. , 'Ought dialysis patients with atrial fibrillation be treated with oral anticoagulants? ' (2005 ) 101 Int. J. Cardiol. : 489 -.

    • Search Google Scholar
  • Wrigh, J. R., Kalra, P. A.: Ought dialysis patients with atrial fibrillation be treated with oral anticoagulants? Int. J. Cardiol., 2003, 87 , 139–141.

    Kalra P. A. , 'Ought dialysis patients with atrial fibrillation be treated with oral anticoagulants? ' (2003 ) 87 Int. J. Cardiol. : 139 -141.

    • Search Google Scholar
  • Fox, C. S., Larson, M. G., Leip, E. P. és mtsai: Predictors of new-onset kidney disease in a community-based population. JAMA, 2004, 291 , 844–850.

    Leip E. P. , 'Predictors of new-onset kidney disease in a community-based population ' (2004 ) 291 JAMA : 844 -850.

    • Search Google Scholar
  • Agarwal, R.: Antihypertensive agents and arterial stiffness: relevance to reducing cardiovascular risk in the chronic kidney disease patient. Curr. Opin. Nephrol. Hypertens., 2007, 16 , 409–415.

    Agarwal R. , 'Antihypertensive agents and arterial stiffness: relevance to reducing cardiovascular risk in the chronic kidney disease patient ' (2007 ) 16 Curr. Opin. Nephrol. Hypertens. : 409 -415.

    • Search Google Scholar
  • Weir, M. R.: The role of combination antihypertensive therapy in the prevention and treatment of chronic kidney disease. Am. J. Hypertens., 2005, 18 , 100S–105S.

    Weir M. R. , 'The role of combination antihypertensive therapy in the prevention and treatment of chronic kidney disease ' (2005 ) 18 Am. J. Hypertens. : 100S -105S.

    • Search Google Scholar
  • Fathi, R., Isbel, N., Short, L. és mtsai: The effect of long-term aggressive lipid lowering on ischemic and atherosclerotic burden in patients with chronic kidney disease. Am. J. Kidney Dis., 2004, 43 , 45–52.

    Short L. , 'The effect of long-term aggressive lipid lowering on ischemic and atherosclerotic burden in patients with chronic kidney disease ' (2004 ) 43 Am. J. Kidney Dis. : 45 -52.

    • Search Google Scholar
  • Wanner, C., Drechsler, C., Krane, V.: Lipid metabolism in chronic kidney disease: the role of statins in cardiovascular risk. J. Ren. Nutr., 2007, 17 , 75–78.

    Krane V. , 'Lipid metabolism in chronic kidney disease: the role of statins in cardiovascular risk ' (2007 ) 17 J. Ren. Nutr. : 75 -78.

    • Search Google Scholar
  • Baber, U., Toto, R. D., de Lemos, J. A.: Statins and cardiovascular risk reduction in patients with chronic kidney disease and end-stage renal failure. Am. Heart J., 2007, 153 , 471–477.

    Lemos J. A. , 'Statins and cardiovascular risk reduction in patients with chronic kidney disease and end-stage renal failure ' (2007 ) 153 Am. Heart J. : 471 -477.

    • Search Google Scholar
  • Anan, F., Takahashi, N., Shimomura, T. és mtsai: Hyperhomocysteinemia is a significant risk factor for silent cerebral infarction in patients with chronic renal failure undergoing hemodialysis. Metabolism., 2006, 55 , 656–661.

    Shimomura T. , 'Hyperhomocysteinemia is a significant risk factor for silent cerebral infarction in patients with chronic renal failure undergoing hemodialysis ' (2006 ) 55 Metabolism. : 656 -661.

    • Search Google Scholar
  • Jamison, R. L., Hartigan, P., Kaufman, J. S. és mtsai: Veterans Affairs Site Investigators. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial. JAMA, 2007, 298 , 1163–1170.

    Kaufman J. S. , 'Veterans Affairs Site Investigators. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial ' (2007 ) 298 JAMA : 1163 -1170.

    • Search Google Scholar

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Nov 2020 11 1 0
Dec 2020 21 0 0
Jan 2021 14 0 0
Feb 2021 7 0 0
Mar 2021 12 0 0
Apr 2021 9 1 1
May 2021 0 0 0